{"id":547496,"date":"2021-06-14T17:24:01","date_gmt":"2021-06-14T17:24:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=547496"},"modified":"2021-06-14T17:24:01","modified_gmt":"2021-06-14T17:24:01","slug":"peanut-allergy-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-dbv-technologies-anaptysbio-cam-allergy-and-many-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/peanut-allergy-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-dbv-technologies-anaptysbio-cam-allergy-and-many-others_547496.html","title":{"rendered":"Peanut Allergy Market: Industry Analysis, Key Companies, Emerging Drugs and Treatment by DelveInsight | DBV Technologies, AnaptysBio, Cam Allergy, and Many Others"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1623658853.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Peanut Allergy Market: Industry Analysis, Key Companies, Emerging Drugs and Treatment by DelveInsight | DBV Technologies, AnaptysBio, Cam Allergy, and Many Others\" src=\"https:\/\/www.abnewswire.com\/uploads\/1623658853.jpeg\" alt=\"Peanut Allergy Market: Industry Analysis, Key Companies, Emerging Drugs and Treatment by DelveInsight | DBV Technologies, AnaptysBio, Cam Allergy, and Many Others\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Peanut Allergy Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &ldquo;<strong>Peanut Allergy Market Insights, Epidemiology, and Market Forecast-2030<\/strong>&rdquo; report delivers an in-depth understanding of the Peanut Allergy, historical and forecasted epidemiology as well as the&nbsp; Peanut Allergy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some key facts of <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/peanut-allergy-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Peanut Allergy Market<\/a> Report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>The prevalence has increased steadily over the past decade, mostly in the Western world. As per DelveInsight estimates, the total prevalent population of Peanut Allergy in the 7MM was found to be 8,640,527 in 2017. The estimates show higher prevalence in the US with 4,659,471 cases in 2017 and is a growing health problem in the US, specifically in children.<\/li>\n<li>Among the EU5 countries, France had the highest prevalent population of Peanut Allergy with 614,959 cases, followed by Germany and the United Kingdom.<\/li>\n<li>As per DelveInsight analysis, it is observed that Japan has the least number of prevalent cases (1,548,318 for 2017) of Peanut Allergy, among the 7MM.<\/li>\n<li>In terms of Gender-specific, most of the patients diagnosed with Peanut Allergy were male.<\/li>\n<li>The highest number of people affected with Peanut Allergy was found in the age group of 65 and above years.<\/li>\n<li>Based on the Severity, the diagnosed cases were divided into mild, moderate to severe. The total cases of mild and moderate to severe Peanut Allergy in the US varied as 2,341,384 and 1,153,219 respectively.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for sample pages:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>The key players involved in the&nbsp;Peanut Allergy market:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>DBV Technologies,&nbsp;<\/li>\n<li>AnaptysBio,&nbsp;<\/li>\n<li>Cam Allergy<\/li>\n<li>HAL Allergy B.V<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key benefits of the<\/strong> <strong>Peanut Allergy report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Peanut Allergy market report covers a descriptive overview and comprehensive insight of the Peanut Allergy epidemiology and Peanut Allergy market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Peanut Allergy market report provides insights on the current and emerging therapies.<\/li>\n<li>Peanut Allergy market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Peanut Allergy market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Peanut Allergy market.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for sample pages:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Peanut Allergy Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">An allergic response to peanuts usually occurs within minutes after exposure. Peanut allergy signs and symptoms can include: Skin reactions, such as hives, redness or swelling. Itching or tingling in or around the mouth and throat. Digestive problems, such as diarrhea, stomach cramps, nausea or vomiting.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/peanut-allergy-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Peanut Allergy Drugs<\/a> covered:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Viaskin Peanut<\/li>\n<li>ANB020&nbsp;<\/li>\n<li>CA002&nbsp;<\/li>\n<li>HAL-MPE1&nbsp;<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for sample pages:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Peanut Allergy Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Peanut Allergy Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Peanut Allergy Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Peanut Allergy Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Peanut Allergy<\/p>\n<p style=\"text-align: justify;\">9. Peanut Allergy Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Peanut Allergy Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Peanut Allergy Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Peanut Allergy Market Analysis (2017&ndash;2030)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Peanut Allergy Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Detailed TOC:&nbsp;https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About&nbsp;<\/strong><strong>DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.&nbsp; Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform&nbsp;PharmDelve.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=peanut-allergy-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-dbv-technologies-anaptysbio-cam-allergy-and-many-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/peanut-allergy-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/peanut-allergy-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/peanut-allergy-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=peanut-allergy-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-dbv-technologies-anaptysbio-cam-allergy-and-many-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Peanut Allergy Market DelveInsight&rsquo;s &ldquo;Peanut Allergy Market Insights, Epidemiology, and Market Forecast-2030&rdquo; report delivers an in-depth understanding of the Peanut Allergy, historical and forecasted epidemiology as well as the&nbsp; Peanut Allergy market trends in the United States, EU5 (Germany, Spain, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/peanut-allergy-market-industry-analysis-key-companies-emerging-drugs-and-treatment-by-delveinsight-dbv-technologies-anaptysbio-cam-allergy-and-many-others_547496.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-547496","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/547496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=547496"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/547496\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=547496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=547496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=547496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}